Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
alitretinoin cytochrome p450 26c1 small molecule NA drugbank AIDS with Kaposi's sarcoma[MeSHID:C554498]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Kaposi Sarcoma[MeSHID:D012514]		 NA approved,investigational unknown
alitretinoin insulin-like growth factor-binding protein 3 small molecule NA drugbank AIDS with Kaposi's sarcoma[MeSHID:C554498]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Kaposi Sarcoma[MeSHID:D012514]		 NA approved,investigational unknown
alitretinoin pregnancy-specific beta-1-glycoprotein 5 small molecule NA drugbank AIDS with Kaposi's sarcoma[MeSHID:C554498]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Kaposi Sarcoma[MeSHID:D012514]		 NA approved,investigational unknown
alitretinoin retinoic acid receptor alpha small molecule NA drugbank , DGIDB AIDS with Kaposi's sarcoma[MeSHID:C554498]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Kaposi Sarcoma[MeSHID:D012514]		 2.74 approved,investigational agonist
alitretinoin retinoic acid receptor beta small molecule Successful target TTD , drugbank , DGIDB AIDS with Kaposi's sarcoma[MeSHID:C554498]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Kaposi Sarcoma[MeSHID:D012514]		 4.71 approved,investigational agonist
alitretinoin retinoic acid receptor gamma small molecule Successful target TTD , drugbank , DGIDB AIDS with Kaposi's sarcoma[MeSHID:C554498]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Kaposi Sarcoma[MeSHID:D012514]		 3.74 approved,investigational agonist
alitretinoin retinoic acid receptor rxr-alpha small molecule Successful target TTD , drugbank , DGIDB AIDS with Kaposi's sarcoma[MeSHID:C554498]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Kaposi Sarcoma[MeSHID:D012514]		 1.45 approved,investigational agonist
alitretinoin retinoic acid receptor rxr-beta small molecule Successful target TTD , drugbank , DGIDB AIDS with Kaposi's sarcoma[MeSHID:C554498]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Kaposi Sarcoma[MeSHID:D012514]		 7.86 approved,investigational agonist
alitretinoin retinoic acid receptor rxr-gamma small molecule Successful target TTD , drugbank , DGIDB AIDS with Kaposi's sarcoma[MeSHID:C554498]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Kaposi Sarcoma[MeSHID:D012514]		 8.84 approved,investigational agonist
click here to return to the previous page